Allofiber
Payments companies reported to CMS as associated with Allofiber. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Allofiber, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Allofiber
These are the largest totals companies reported as associated with Allofiber. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Nicolas Piuzzi | Cleveland, OH | Adult Reconstructive Orthopaedic Surgery | $12,691.48 |
| Philipp Leucht | New York, NY | Orthopaedic Trauma | $8,893.08 |
| John Clements | Roanoke, VA | Podiatrist | $7,437.50 |
| Gregory Carolan | Bethlehem, PA | Orthopaedic Surgery | $5,312.50 |
| Steven Sands | Oklahoma City, OK | Orthopaedic Trauma | $4,000.00 |
| Suneel Bhat | Norfolk, VA | Orthopaedic Trauma | $4,000.00 |
| Eric Tan | Los Angeles, CA | Foot and Ankle Surgery | $2,700.00 |
| Kaitlyn Loesel | Louisville, KY | $1,289.40 | |
| Nicholas Laco | Louisville, KY | Foot & Ankle Surgery | $1,267.43 |
| Zachery Weyandt | Louisville, KY | Podiatrist | $1,164.72 |
Prescribed Allofiber?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.